Samchundang Pharm CEO Jeon Inseok Withdraws 250 Billion Won Block Deal Plan
Samchundang Pharm announced on April 6 that CEO Jeon Inseok has withdrawn the plan for a block deal of shares worth 250 billion won, which was disclosed on March 24.
CEO Jeon cited the spread of market distrust and the damage to shareholder value as reasons for canceling the block deal. The share sale was originally intended to cover tax payments such as gift taxes. However, suspicions emerged in the market that the company had exaggerated the size of its U.S. supply contract to facilitate the block deal.
CEO Jeon stated, "There was absolutely no fabrication or exaggeration regarding the contract details, but as negative suspicions continued to be raised and shareholders were being harmed, I could not stand by as CEO. I decided to withdraw the block deal, believing that protecting the company's fundamental value should take precedence over fulfilling my personal financial obligations."
CEO Jeon is scheduled to hold a press briefing later this afternoon to provide a detailed explanation of the circumstances behind the block deal cancellation, address suspicions related to the independent platform 'S-PASS,' and clarify the nature of the U.S. contract.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
He added, "The most urgent task is to restore market trust through business performance," and continued, "I will prove the company's value with specific figures and results for the milestones scheduled in the second half of the year and seek a revaluation of our corporate value."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.